comparemela.com
Home
Live Updates
Evozyne Announces Multi-Target Research Collaboration and License Agreement with Takeda to Develop Next-Generation Gene Therapies : comparemela.com
Evozyne Announces Multi-Target Research Collaboration and License Agreement with Takeda to Develop Next-Generation Gene Therapies
/PRNewswire/ -- Evozyne, Inc., an adaptive biology company pioneering evolution-based design of proteins, founded by Paragon Biosciences, announced today that...
Related Keywords
Evelyn Oconnor
,
Jeff Aronin
,
Rama Ranganathan
,
Madhu Natarajan
,
Emalex Biosciences
,
Evozyne Inc
,
,
Evozyne Co Founder
,
Rare Diseases Drug Discovery Unit
,
Chief Scientific Officer Rama Ranganathan
,
Natural Machines
,
Castle Creek Biosciences
,
Harmony Biosciences
,
Qlarity Imaging
,
Paragon Innovation Capital
,
Evozyne
,
Nc
,
comparemela.com © 2020. All Rights Reserved.